CSTB p.Gln26Ter
c.76C>T · VCV3376548
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Consequence | nonsense (stop-gain) | predicted loss-of-function |
|---|---|---|
| NMD | predicted | premature termination codon in exon 2 of 3 |
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 4.4 | GERP -0.53, phastCons 1 |
| Overall | ||
| CADD | 38.0 | PHRED · no single calibrated threshold — expert panels disagree |
Predicted loss-of-function is descriptive, not an applied PVS1 code.
Population frequency
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CSTB
- Protein
- p.Gln26Ter
- Coding
- c.76C>T
- MANE Select
- NM_000100
- Type
- single nucleotide variant
- Location
- chr21:43774750 (GRCh38)
- Gene constraint
- LOEUF 1.681 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 95.81 · 3 PDB
- Residue 26
- an α-helix
Disease context
Unverricht-Lundborg syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Progressive myoclonic epilepsy type 1 (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Adolescent, Childhood
- Prevalence
- 1-9 / 100 000 (Finland)
Similar variants
- CSTB c.67-1G>C Pathogenic ★★ same condition
- CSTB p.Arg68Ter Pathogenic ★★ same condition
- CSTB p.Gln22Ter Pathogenic/Likely pathogenic ★★ same condition
- CSTB p.Gln46Ter Pathogenic/Likely pathogenic ★★ same condition
- CSTB p.Tyr53Cys Uncertain significance ★★ ⚠ same condition
- CSTB p.Val57Leu Uncertain significance ★★ ⚠ same condition
- CSTB c.67-3T>C Benign/Likely benign ★★ same condition
- CSTB c.-54C>T Benign ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cstb-p-gln26ter (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown